Pasithea Therapeutics Corp. (KTTA) Insider Trading Activity

NASDAQ$0.5-0.03 (-5.66%)
Market Cap
$17.71M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
232 of 849
Rank in Industry
135 of 491

KTTA Insider Trading Activity

KTTA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$202,999
4
100
Sells
$0
0
0

Related Transactions

STEINMAN LAWRENCEdirector
1
$100,000
0
$0
$100,000
Coastlands Capital LP10 percent owner
1
$53,000
0
$0
$53,000
Dumesnil Simondirector
1
$25,000
0
$0
$25,000
Marques TiagoChief Executive Officer
1
$25,000
0
$0
$25,000

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.

Insider Activity of Pasithea Therapeutics Corp.

Over the last 12 months, insiders at Pasithea Therapeutics Corp. have bought $202,999 and sold $0 worth of Pasithea Therapeutics Corp. stock.

On average, over the past 5 years, insiders at Pasithea Therapeutics Corp. have bought $319,447 and sold $792 worth of stock each year.

Highest buying activity among insiders over the last 12 months: STEINMAN LAWRENCE (director) — $100,000. Coastlands Capital LP (10 percent owner) — $53,000. Dumesnil Simon (director) — $25,000.

The last purchase of 100,000 shares for transaction amount of $53,000 was made by Coastlands Capital LP (10 percent owner) on 2026‑06‑17.

List of Insider Buy and Sell Transactions, Pasithea Therapeutics Corp.

2026-06-17PurchaseCoastlands Capital LP10 percent owner
100,000
1.4178%
$0.53
$53,000
-2.54%
2025-11-28PurchaseSTEINMAN LAWRENCEdirector
133,333
0.9139%
$0.75
$100,000
-52.86%
2025-11-28PurchaseMarques TiagoChief Executive Officer
33,333
0.2285%
$0.75
$25,000
-52.86%
2025-11-28PurchaseDumesnil Simondirector
33,333
0.2285%
$0.75
$25,000
-52.86%
2025-05-12SaleMarques TiagoChief Executive Officer
960
0.015%
$0.82
$792
-11.40%
2023-06-02PurchaseSTEINMAN LAWRENCEdirector
30,000
0.124%
$0.43
$12,930
-5.00%
2022-10-17PurchaseDelaney Daviddirector
1,000
0.004%
$1.11
$1,110
-53.15%
2022-09-29PurchaseShahinian EricMember of 10% owner group
6,710
0.0248%
$1.16
$7,757
-50.85%
2022-09-28PurchaseCamac Partners, LLC
6,710
0.0243%
$1.16
$7,757
-51.42%
2022-09-28PurchaseShahinian EricMember of 10% owner group
57,647
0.2151%
$1.19
$68,542
-51.42%
2022-09-06PurchaseShahinian EricMember of 10% owner group
21,748
0.0814%
$1.13
$24,632
-47.37%
2022-09-02PurchaseShahinian EricMember of 10% owner group
11,507
0.0429%
$1.14
$13,105
-47.87%
2022-09-01PurchaseShahinian EricMember of 10% owner group
55,646
0.2051%
$1.13
$62,630
-47.83%
2022-09-01PurchaseCamac Partners, LLC
55,646
0.2051%
$1.13
$62,630
-47.83%
2022-08-30PurchaseShahinian EricMember of 10% owner group
17,828
0.0658%
$1.15
$20,452
-48.72%
2022-08-29PurchaseCamac Partners, LLC
17,828
0.065%
$1.15
$20,452
-49.37%
2022-08-29PurchaseShahinian EricMember of 10% owner group
5,000
0.0186%
$1.17
$5,841
-49.37%
2022-08-19PurchaseLeonite Capital LLC
54,644
0.2002%
$1.30
$70,939
-55.06%
2022-08-17PurchaseShahinian EricMember of 10% owner group
155,773
0.5629%
$1.21
$188,283
-52.38%
2022-08-17PurchaseCamac Partners, LLC
155,773
0.5629%
$1.21
$188,283
-52.38%
Total: 20
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Coastlands Capital LP10 percent owner
3835035
11.4772%
$2.03M10
STEINMAN LAWRENCEdirector
199691
0.5976%
$105,836.2320
Marques TiagoChief Executive Officer
73334
0.2195%
$38,867.0211
Dumesnil Simondirector
35833
0.1072%
$18,991.4910
Shahinian EricMember of 10% owner group
1788415
5.3522%
$947,859.9580
<0.0001%
Camac Partners, LLC
1788415
5.3522%
$947,859.9540
<0.0001%
Delaney Daviddirector
227521
0.6809%
$120,586.1310
<0.0001%
Leonite Capital LLC
54644
0.1635%
$28,961.3210
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$18,815,063
62
-6.45%
$13.7M
$1,993,425
46
-21.91%
$13.95M
$931,435
28
16.31%
$24.8M
$226,127
22
-27.62%
$21.96M
$37,200,153
21
-47.67%
$12.66M

KTTA Institutional Investors: Active Positions

Increased Positions19+95%12M+2,030.4%
Decreased Positions8-40%117,811-19.24%
New Positions12New12MNew
Sold Out Positions5Sold Out87,960Sold Out
Total Postitions31+55%13M+2,011.16%

KTTA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Advisorshares Investments Llc$307.001.12%257,696+64,149+33.14%2025-09-30
Citadel Advisors Llc$80.000.29%67,341+20,483+43.71%2025-09-30
Vanguard Group Inc$64.000.23%53,815+53,815New2025-09-30
Two Sigma Investments, Lp$43.000.16%35,760+35,760New2025-09-30
Xtx Topco Ltd$41.000.15%34,358+34,358New2025-09-30
Renaissance Technologies Llc$37.000.13%30,700+30,700New2025-09-30
Geode Capital Management, Llc$30.000.11%25,475+25,475New2025-09-30
Virtu Financial Llc$30.000.11%25,075+25,075New2025-09-30
Jane Street Group, Llc$30.000.11%25,053+25,053New2025-09-30
Two Sigma Securities, Llc$25.000.09%20,846+20,846New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.